Wenshuang Zeng
Overview
Explore the profile of Wenshuang Zeng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jin L, Zou Z, Wang Q, Zeng W, Jiang Q, Chen J, et al.
Ther Adv Neurol Disord
. 2025 Feb;
18:17562864251319656.
PMID: 39974170
Background: Efgartigimod is an approved biologic for generalized myasthenia gravis (gMG), which is an autoimmune disease and can potentially be life-threatening. However, the therapeutic response to efgartigimod among the acetylcholine...
2.
Luo S, Jiang Q, Zeng W, Wang Q, Zou Z, Yu Y, et al.
Ann Clin Transl Neurol
. 2024 Jul;
11(8):2212-2221.
PMID: 38973109
Objective: Efgartigimod, a neonatal Fc receptor antagonist, facilitates antibody degradation including pathogenic IgGs. The ADAPT study demonstrated the tolerability and efficacy of efgartigimod in the treatment of generalized myasthenia gravis...
3.
Deng Z, Li L, Jing Z, Luo X, Yu F, Zeng W, et al.
Environ Int
. 2024 Jun;
190:108806.
PMID: 38908272
Background: Emerging evidence has shown the potential involvement of phthalates (PAEs) exposure in the development of dementia with Lewy bodies (DLB). Metabolomics can reflect endogenous metabolites variation in the progress...
4.
5.
Liu Y, Cui Y, Xiao H, Cai J, Zeng W, Lu Z
J Neuroophthalmol
. 2023 Feb;
44(1):e82-e84.
PMID: 36729821
No abstract available.
6.
Zhou Y, Chen J, Li Z, Tan S, Yan C, Luo S, et al.
Front Neurol
. 2022 Apr;
13:879261.
PMID: 35463138
Introduction: Antibodies to MuSK identify a rare subtype of myasthenia gravis (MuSK-MG). In western countries, the onset age of MuSK-MG peaks in the late 30's while it is unknown in...
7.
Xiao H, Zeng W, Li L, Li L, Cui Y, Wang J, et al.
Front Neurol
. 2020 Aug;
11:642.
PMID: 32733365
This study aimed to investigate the efficacy and safety of low-dose rituximab (RTX) in the treatment of neuromyelitis optica spectrum disorders (NMOSD) patients. NMOSD patients were treated with RTX at...
8.
Chen J, Zeng W, Han C, Wu J, Zhang H, Tong X
Neuropathology
. 2016 Mar;
36(5):485-489.
PMID: 26947586
Mutations in the gene encoding caveolin-3 (CAV3) can cause a broad spectrum of clinical phenotypes, including limb girdle muscular dystrophy, rippling muscle disease, distal myopathy (MD), idiopathic persistent elevation of...
9.
Xu W, Hang J, Cao T, Shi R, Zeng W, Deng Y, et al.
J Occup Health
. 2010 Jul;
52(5):257-62.
PMID: 20610905
Objectives: Carotid intima-media thickness (CIMT) can be used as a surrogate marker for cardiovascular health, and job stress is a risk factor for cardiovascular disease. However, there have been a...